Cipla EU to invest EUR 15 million in ETHRIS, initiating a strategic collaboration Kumar Jeetendra | December 29, 2022 Mumbai, India and Munich, Germany: December 29, 2022: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that its wholly owned UK subsidiary, Cipla (EU) Limited (“Cipla EU”) has signed definitive agreements for equity investment of EUR 15 million in Ethris GmbH (“Ethris”), a global leader in delivering mRNAs directly to …
USFDA approves Alembic Pharmaceuticals’ Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe Kumar Jeetendra | December 26, 2022 26th December, 2022, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Prefilled Syringe. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), …
Opportunity for Mary kay research and development: Senior Scientist R&D Compliance Kumar Jeetendra | December 21, 2022 Mary Kay’s R&D teams are enthusiastic about science. They do ongoing research on products that enable our consultants to provide their end-users with an experience of unparalleled quality and benefit. People must feel confident about themselves and their choice of Mary Kay when using our products. Our research teams travel internationally in search of innovative …
Clinithink and AstraZeneca Launch First of its Kind AI Project Aimed at Detecting Early-Stage Lung Cancer Kumar Jeetendra | December 15, 2022 Clinithink, the company that has developed the world’s first Healthcare AI capable of truly understanding unstructured medical notes, has partnered with AstraZeneca Oncology UK in a new project that aims to find patients with lung cancer at an early stage where treatment can be more effective. The project announced today hopes to demonstrate potential savings …
ENTOD Pharmaceuticals Launches Week-Long Initiative to Raise Awareness and Recognise the Growing Threat of Myopia in Children Kumar Jeetendra | November 14, 2022 In an effort to bring awareness of the myopia epidemic in India and the growing number of myopic children, ENTOD Pharmaceuticals is supporting a week-long Myopia Awareness Campaign organised by ENTOD Eye Health Foundation in association with the Strabismus and Pediatric Ophthalmological Society of India (SPOSI) from November 14-20, observes National Myopia Week in India. …
IOL Chemicals and Pharmaceuticals receives EDQM certification to supply Pantoprazole Sodium Sesquihydrate API in European market Kumar Jeetendra | November 7, 2022 IOL Chemicals and Pharmaceuticals Limited (IOL), a leading manufacturer of pharmaceutical (APIs) and specialty chemicals, announced receiving EDQM certification to supply Pantoprazole Sodium Sesquihydrate API across European market. Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion. The company started production of Pantoprazole Sodium Sesquihydrate in Q3 FY …
Alembic Pharmaceuticals announces its first injectable product approval from its General Sterile Facility – Final Approval for Glycopyrrolate Injection USP Kumar Jeetendra | November 1, 2022 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Glycopyrrolate Injection USP, 0.2 mg/1 mL and 0.4 mg/2 mL (0.2 mg/mL) Single-dose Vials and 1 mg/5 mL (0.2 mg/mL) and 4 mg/20 mL (0.2 mg/mL) Multiple-dose Vials. …
Alembic Pharmaceuticals receives USFDA Final Approval for Paclitaxel Injection USP Kumar Jeetendra | October 27, 2022 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Paclitaxel Injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL (6 mg/mL) Multiple-Dose Vials. This is the first product approval …
Aragen to operationalize cutting-edge formulation manufacturing facility Kumar Jeetendra | October 21, 2022 Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO), today announced that it will operationalize its state-of-the-art formulation manufacturing facility in the Mallapur campus, Hyderabad, India by January 2023. The 12,000 square feet new facility will strengthen the company’s ability to deliver clinical supplies to customers through its integrated drug substance and drug product …
Parexel Recognized by Frost & Sullivan with 2022 Global Customer Value Leadership Award Kumar Jeetendra | October 19, 2022 Based on its recent analysis of the global decentralized clinical trials (DCT) industry, Frost & Sullivan has recognized leading global clinical research organization (CRO) Parexel with the 2022 Global Customer Value Leadership Award. Parexel combines in-house expertise, patient and caregiver insights, and cutting-edge technologies to plan, operationalize, and deliver DCTs for biopharmaceutical customers worldwide while …
VINCOV-19, an antidote, and a cure against COVID-19, successfully completes Phase 2 Clinical Trials Kumar Jeetendra | October 13, 2022 VINS Bioproducts Limited, a leading immunological company, based in Hyderabad, in collaboration with the Centre for Cellular and Molecular Biology (CCMB) and the University of Hyderabad (UoH), announced the successful completion of Phase 2 Clinical Trials of VINCOV-19, India’s first antidote and a cure against SARS-CoV-2 virus. VINCOV-19 is now ready for market authorization and …
Cipla’s Indore plant joins the World Economic Forum’s (WEF) prestigious Lighthouse Network Kumar Jeetendra | October 11, 2022 Cipla Limited (BSE: 500087; NSE: CIPLA EQ) (“Cipla”) today announced that its Indore Oral Solid Dosage (OSD) plant has been designated by the World Economic Forum as an ‘Advanced Fourth Industrial Revolution (4IR) Lighthouse’. This is the first Cipla facility to receive the coveted recognition. The organisation is amongst the first pharmaceutical companies in India …
